Molecular imaging developer Sofie Biosciences has acquired Houston Cyclotron Partners, a cyclotron radiopharmacy based in Houston.
The acquisition brings the number of Sofie's operational radiopharmacies to 17, which collectively provide services to more than 400,000 patients at roughly 700 clinics throughout the U.S., according to the company. Sofie also plans to offer its services to five additional markets in the next two years.
